These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38214694)

  • 1. Self-Assembled Nanocarrier Delivery Systems for Bioactive Compounds.
    Zhang Y; Zhang Y; Ding R; Zhang K; Guo H; Lin Y
    Small; 2024 Jun; 20(26):e2310838. PubMed ID: 38214694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing anthocyanin Oral delivery: Effects of food biomacromolecule types on Nanocarrier performance for enhanced bioavailability.
    Yuan Y; Hu Y; Huang J; Liu B; Li X; Tian J; de Vries R; Li B; Li Y
    Food Chem; 2024 Oct; 454():139682. PubMed ID: 38797106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery.
    Ismail R; Phan TNQ; Laffleur F; Csóka I; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2020 Jul; 152():10-17. PubMed ID: 32371152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments.
    Khairnar P; Phatale V; Shukla S; Tijani AO; Hedaoo A; Strauss J; Verana G; Vambhurkar G; Puri A; Srivastava S
    Mol Pharm; 2024 May; 21(5):2118-2147. PubMed ID: 38660711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids and their derivatives: by-products used as essential building blocks for modern drug delivery systems.
    Tu Y; Zhu L
    Curr Drug Targets; 2014 May; 15(5):502-17. PubMed ID: 24597533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
    Yang M; Gu Y; Tang X; Wang T; Liu J
    Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms.
    Kaushik N; Borkar SB; Nandanwar SK; Panda PK; Choi EH; Kaushik NK
    J Nanobiotechnology; 2022 Mar; 20(1):152. PubMed ID: 35331246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophobic ion-pairs and lipid-based nanocarrier systems: The perfect match for delivery of BCS class 3 drugs.
    Phan TNQ; Shahzadi I; Bernkop-Schnürch A
    J Control Release; 2019 Jun; 304():146-155. PubMed ID: 31075345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shining Light on Polymeric Drug Nanocarriers with Fluorescence Correlation Spectroscopy.
    Schmitt S; Nuhn L; Barz M; Butt HJ; Koynov K
    Macromol Rapid Commun; 2022 Jun; 43(12):e2100892. PubMed ID: 35174569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-based nanocarriers for drug delivery.
    Ma Y; Nolte RJ; Cornelissen JJ
    Adv Drug Deliv Rev; 2012 Jun; 64(9):811-25. PubMed ID: 22285585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
    Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
    Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
    Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
    Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences.
    Zhang A; Meng K; Liu Y; Pan Y; Qu W; Chen D; Xie S
    Adv Colloid Interface Sci; 2020 Oct; 284():102261. PubMed ID: 32942181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review.
    Kothapalli P; Vasanthan M
    Ther Deliv; 2024 Feb; 15(2):135-155. PubMed ID: 38214118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance.
    Meng T; Lu B; Shao S; Yuan M; Liu X; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Dec; 534(1-2):368-377. PubMed ID: 29051118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
    Pathak K; Keshri L; Shah M
    Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid based nanocarriers: a translational perspective.
    Mishra DK; Shandilya R; Mishra PK
    Nanomedicine; 2018 Oct; 14(7):2023-2050. PubMed ID: 29944981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.
    Ganesan P; Ramalingam P; Karthivashan G; Ko YT; Choi DK
    Int J Nanomedicine; 2018; 13():1569-1583. PubMed ID: 29588585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.